John Scandling

Kidney transplant nephrologist, Tolerance induction protocol specialist, Desensitization program specialist

Professor of Medicine (Nephrology) at the Stanford University Medical Center

Kidney and Pancreas Transplant Program

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-9891
Learn More About the Clinic Getting Here Make An Appointment

Kidney and Pancreas Transplant Program at Boswell Building

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-725-9891
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: West Virginia University Hospital (1981) WV

Fellowship: University of Rochester (1983) NY

Board Certification: Nephrology, American Board of Internal Medicine (1984)

Board Certification: Internal Medicine, American Board of Internal Medicine (1981)

Internship: West Virginia University Hospital (1981) WV

Medical Education: Medical College of Virginia (1978) VA

M.D., Medical College of Virginia (1978)

A.B., Davidson College, Psychology (1974)

Administrative Appointments

Program Director, Stanford Transplant Nephrology Fellowship Training Program (2006 - Present)

Program Director, Stanford Nephrology Fellowship Training Program (2005 - Present)

Medical Director, Stanford Adult Kidney and Pancreas Transplantation (1992 - Present)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Sarwal, M., & Strober, S. (2012). Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 12(5), 1133-1145.

Living donor evaluation and exclusion: the Stanford experience
Lapasia, J. B., Kong, S.- yee, Busque, S., Scandling, J. D., Chertow, G. M., & Tan, J. C. (2011). Living donor evaluation and exclusion: the Stanford experience. CLINICAL TRANSPLANTATION, 25(5), 697-704.

United Network for Organ Sharing (UNOS) Organ Allocation Policy and Kidney Utilization
Scandling, J. D., & Norman, D. J. (2010). United Network for Organ Sharing (UNOS) Organ Allocation Policy and Kidney Utilization. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(1), 7-9.

Tolerance and chimerism after renal and hematopoietic-cell transplantation.
Scandling, J. D., Busque, S., Dejbakhsh-Jones, S., Benike, C., Millan, M. T., & Strober, S. (2008). Tolerance and chimerism after renal and hematopoietic-cell transplantation. New England journal of medicine, 358(4), 362-368.

High rates of coronary artery stenosis detected by angiography in diabetic renal transplant candidates
Scandling, J. D. (2007). High rates of coronary artery stenosis detected by angiography in diabetic renal transplant candidates. NATURE CLINICAL PRACTICE NEPHROLOGY, 3(4), 194-195.

Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation
Ma, I. Wy., Valantine, H. A., Shibata, A., Waskerwitz, J., Dafoe, D. C., & Scandling, J. D. (2006). Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation. CLINICAL TRANSPLANTATION, 20(2), 139-146.

Kidney transplant candidate evaluation
Scandling, J. D. (2005). Kidney transplant candidate evaluation. SEMINARS IN DIALYSIS, 18(6), 487-494.

Renal juxtaglomerular apparatus hyperplasia
Troxell, M. L., Scandling, J. D., & Sibley, R. K. (2005). Renal juxtaglomerular apparatus hyperplasia. NEPHROLOGY DIALYSIS TRANSPLANTATION, 20(10), 2282-2283.

Dual-kidney transplantation with organs from expanded criteria donors: A long-term follow-up
Tan, J. C., Alfrey, E. J., Dafoe, D. C., Millan, M. T., & Scandling, J. D. (2004). Dual-kidney transplantation with organs from expanded criteria donors: A long-term follow-up. TRANSPLANTATION, 78(5), 692-696.

Approaches to transplantation tolerance in humans
Strober, S., Lowsky, R. J., Shizuru, J. A., Scandling, J. D., & Millan, M. T. (2004). Approaches to transplantation tolerance in humans. TRANSPLANTATION, 77(6), 932-936.

A randomized, placebo-controlled trial of IGF-1 for delayed graft function: A human model to study postischemic ARF
Hladunewich, M. A., Corrigan, G., Derby, G. C., Ramaswamy, D., Kambham, N., & Myers, B. D. (2003). A randomized, placebo-controlled trial of IGF-1 for delayed graft function: A human model to study postischemic ARF. KIDNEY INTERNATIONAL, 64(2), 593-602.

Quantification of immunosuppression by flow cytometry in stable renal transplant recipients
Stalder, M., Birsan, T., Holm, B., Haririfar, M., Scandling, J., & Morris, R. E. (2003). Quantification of immunosuppression by flow cytometry in stable renal transplant recipients. THERAPEUTIC DRUG MONITORING, 25(1), 22-27.

Increased expression of cytotoxic effector molecules: Different interpretations for steroid-based and steroid-free immunosuppression
Satterwhite, T., Chua, M. S., Hsieh, S. C., Chang, S., Scandling, J., & Sarwal, M. M. (2003). Increased expression of cytotoxic effector molecules: Different interpretations for steroid-based and steroid-free immunosuppression. PEDIATRIC TRANSPLANTATION, 7(1), 53-58.

Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation
Millan, T. Lt., Shizuru, J. A., Hoffmann, P., Dejbakhsh-Jones, S., Scandling, J. D., & Strober, S. (2002). Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. TRANSPLANTATION, 73(9), 1386-1391.

Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?
Yorgin, P. D., Scandling, J. D., Belson, A., Sanchez, J., Alexander, S. R., & Andreoni, K. A. (2002). Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?. AMERICAN JOURNAL OF TRANSPLANTATION, 2(5), 429-435.

Maintenance and recovery stages of postischemic acute renal failure in humans
Ramaswamy, D., Corrigan, G., Polhemus, C., Boothroyd, D., Scandling, J., & Myers, B. D. (2002). Maintenance and recovery stages of postischemic acute renal failure in humans. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 282(2), F271-F280.

Revisiting the use of hepatitis B core antibody-positive donor kidneys
Krieger, N. R., Vial, C. M., Millan, M. T., Imperial, J., Dafoe, D. C., & Scandling, J. D. (2001). Revisiting the use of hepatitis B core antibody-positive donor kidneys. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1535-1536.

PAH extraction and estimation of plasma flow in human postischemic acute renal failure
Corrigan, G., Ramaswamy, D., Kwon, O., Sommer, F. G., Alfrey, E. J., & Myers, B. D. (1999). PAH extraction and estimation of plasma flow in human postischemic acute renal failure. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 277(2), F312-F318.

Sodium reabsorption and distribution of Na+/K+-ATPase during postischemic injury to the renal allograft
Kwon, O., Corrigan, G., Myers, B. D., Sibley, R., Scandling, J. D., & NELSON, W. J. (1999). Sodium reabsorption and distribution of Na+/K+-ATPase during postischemic injury to the renal allograft. KIDNEY INTERNATIONAL, 55(3), 963-975.

Plasma glutathione peroxidase and its relationship to renal proximal tubule function
Whitin, J. C., Tham, D. M., Bhamre, S., Ornt, D. B., Scandling, J. D., & Cohen, H. J. (1998). Plasma glutathione peroxidase and its relationship to renal proximal tubule function. MOLECULAR GENETICS AND METABOLISM, 65(3), 238-245.

What is the optimal approach for the end-stage diabetic nephropathy patient considering simultaneous pancreas-kidney transplantation?
Dafoe, D. C., Scandling, J. D., WASKERWITZ, J. A., & Beinin, M. L. (1998). What is the optimal approach for the end-stage diabetic nephropathy patient considering simultaneous pancreas-kidney transplantation?. Advances in renal replacement therapy, 5(3), 232-240.

Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation
Desai, D. M., Scandling, J. D., Knoppel, C., Dafoe, D. C., & Alfrey, E. J. (1998). Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation. TRANSPLANTATION PROCEEDINGS, 30(4), 1552-1554.

Backleak, light junctions, and cell-cell adhesion in postischemic injury to the renal allograft
Kwon, O., NELSON, W. J., Sibley, R., Huie, P., Scandling, J. D., & Myers, B. D. (1998). Backleak, light junctions, and cell-cell adhesion in postischemic injury to the renal allograft. JOURNAL OF CLINICAL INVESTIGATION, 101(10), 2054-2064.

Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine
Lee, C. M., Markezich, A. J., Scandling, J. D., Dafoe, D. C., & Alfrey, E. J. (1998). Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine. JOURNAL OF SURGICAL RESEARCH, 76(2), 131-136.

A review of the kidneys that nobody wanted
Lee, C. M., Scandling, J. D., Pavlakis, M., Markezich, A. J., Dafoe, D. C., & Alfrey, E. J. (1998). A review of the kidneys that nobody wanted. TRANSPLANTATION, 65(2), 213-219.

Expanded criteria for donor kidneys: An update on outcome in single versus dual kidney transplants
Alfrey, E. J., Lee, C. M., Scandling, J. D., Witter, M. M., Carter, J. T., & Dafoe, D. C. (1997). Expanded criteria for donor kidneys: An update on outcome in single versus dual kidney transplants. TRANSPLANTATION PROCEEDINGS, 29(8), 3671-3673.

Bladder augmentation can be problematic with renal failure and transplantation
Alfrey, E. J., Salvatierra, O., Tanney, D. C., Mak, R., Scandling, J. D., & Conley, S. B. (1997). Bladder augmentation can be problematic with renal failure and transplantation. PEDIATRIC NEPHROLOGY, 11(6), 672-675.

Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation
Lee, C. M., Scandling, J. D., Krieger, N. R., Dafoe, D. C., & Alfrey, E. J. (1997). Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation. TRANSPLANTATION, 64(9), 1288-1294.

When should expanded criteria donor kidneys be used for single versus dual kidney transplants?
Alfrey, E. J., Lee, C. M., Scandling, J. D., Pavlakis, M., Markezich, A. J., & Dafoe, D. C. (1997). When should expanded criteria donor kidneys be used for single versus dual kidney transplants?. TRANSPLANTATION, 64(8), 1142-1146.

Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation
Shen, G. K., Alfrey, E. J., Knoppel, C. L., Dafoe, D. C., & Scandling, J. D. (1997). Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation. TRANSPLANTATION, 64(6), 931-933.

Pathophysiology of reduced glomerular filtration rate in delayed graft function
Scandling, J. D., & Myers, B. D. (1997). Pathophysiology of reduced glomerular filtration rate in delayed graft function. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 6(4), 405-409.

Use of an augmented urinary bladder can be catastrophic in renal transplantation
Alfrey, E. J., Conley, S. B., Tanney, D. C., Mak, R., Scandling, J. D., & Salvatierra, O. (1997). Use of an augmented urinary bladder can be catastrophic in renal transplantation. TRANSPLANTATION PROCEEDINGS, 29(1-2), 154-155.

Kidney and kidney/pancreas transplantation at Stanford University Medical Center.
Desai, D. M., Scandling, J. D., Alfrey, E. J., Pavlakis, M., Salvatierra, O., & Dafoe, D. C. (1997). Kidney and kidney/pancreas transplantation at Stanford University Medical Center. Clinical transplants, 135-147.

The kidneys that nobody wanted - Support for the utilization of expanded criteria donors
Lee, C. M., Scandling, J. D., Shen, G. K., Salvatierra, O., Dafoe, D. C., & Alfrey, E. J. (1996). The kidneys that nobody wanted - Support for the utilization of expanded criteria donors. TRANSPLANTATION, 62(12), 1832-1841.

THE UTILITY OF RETROPERITONEAL KIDNEY PLACEMENT IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION
Kuo, P. C., Krieger, N. R., Alfrey, E. J., Scandling, J., & Dafoe, D. C. (1995). THE UTILITY OF RETROPERITONEAL KIDNEY PLACEMENT IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION. CLINICAL TRANSPLANTATION, 9(6), 457-462.

ENDOGENOUS ANP IN POSTISCHEMIC ACUTE RENAL-ALLOGRAFT FAILURE
VINOT, O., Bialek, J., CANAANKUHL, S., Scandling, J. D., Dafoe, D., & Myers, B. D. (1995). ENDOGENOUS ANP IN POSTISCHEMIC ACUTE RENAL-ALLOGRAFT FAILURE. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 269(1), F125-F133.

CLINICAL OUTCOME OF INTERVAL CADAVERIC RENAL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS
Kuo, P. C., Luikart, H., BUSSEHENRY, S., Hunt, S. A., Valantine, H. A., & Dafoe, D. C. (1995). CLINICAL OUTCOME OF INTERVAL CADAVERIC RENAL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS. CLINICAL TRANSPLANTATION, 9(2), 92-97.

THE USE OF SPIRAL COMPUTED-TOMOGRAPHY IN THE EVALUATION OF LIVING DONORS FOR KIDNEY-TRANSPLANTATION
Alfrey, E. J., Rubin, G. D., Kuo, P. C., WASKERWITZ, J. A., Scandling, J. D., & Dafoe, D. C. (1995). THE USE OF SPIRAL COMPUTED-TOMOGRAPHY IN THE EVALUATION OF LIVING DONORS FOR KIDNEY-TRANSPLANTATION. TRANSPLANTATION, 59(4), 643-645.

MECHANISMS OF FILTRATION FAILURE DURING POSTISCHEMIC INJURY OF THE HUMAN KIDNEY - A STUDY OF THE REPERFUSED RENAL-ALLOGRAFT
ALEJANDRO, V., Scandling, J. D., Sibley, R. K., Dafoe, D., Alfrey, E., & Myers, B. D. (1995). MECHANISMS OF FILTRATION FAILURE DURING POSTISCHEMIC INJURY OF THE HUMAN KIDNEY - A STUDY OF THE REPERFUSED RENAL-ALLOGRAFT. JOURNAL OF CLINICAL INVESTIGATION, 95(2), 820-831.

POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND EPSTEIN-BARR-VIRUS PROPHYLAXIS
Kuo, P. C., Dafoe, D. C., Alfrey, E. J., Sibley, R. K., & Scandling, J. D. (1995). POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND EPSTEIN-BARR-VIRUS PROPHYLAXIS. TRANSPLANTATION, 59(1), 135-138.

ENDOVASCULAR STENTING OF THE ABDOMINAL-AORTA FOLLOWING RENAL-TRANSPLANTATION
Kuo, P. C., Alfrey, E. J., Scandling, J. D., Dake, M., & Dafoe, D. C. (1994). ENDOVASCULAR STENTING OF THE ABDOMINAL-AORTA FOLLOWING RENAL-TRANSPLANTATION. TRANSPLANTATION, 58(4), 522-524.

SPIRAL COMPUTED-TOMOGRAPHY IN THE DIAGNOSIS OF TRANSPLANT RENAL-ARTERY STENOSIS
MELL, M. W., Alfrey, E. J., Rubin, G. D., Scandling, J. D., Jeffrey, R. B., & Dafoe, D. C. (1994). SPIRAL COMPUTED-TOMOGRAPHY IN THE DIAGNOSIS OF TRANSPLANT RENAL-ARTERY STENOSIS. TRANSPLANTATION, 57(5), 746-748.

GLOMERULAR SIZE-SELECTIVITY AND MICROALBUMINURIA IN EARLY DIABETIC GLOMERULAR-DISEASE
Scandling, J. D., & Myers, B. D. (1992). GLOMERULAR SIZE-SELECTIVITY AND MICROALBUMINURIA IN EARLY DIABETIC GLOMERULAR-DISEASE. KIDNEY INTERNATIONAL, 41(4), 840-846.

ATRIAL-NATRIURETIC-PEPTIDE AND RESPONSE TO CHANGING PLASMA-VOLUME IN DIABETIC NEPHROPATHY
Lieberman, J. S., Parra, L., Newton, L., Scandling, J. D., LOON, N., & Myers, B. D. (1991). ATRIAL-NATRIURETIC-PEPTIDE AND RESPONSE TO CHANGING PLASMA-VOLUME IN DIABETIC NEPHROPATHY. DIABETES, 40(7), 893-901.

MECHANISM OF POTASSIUM-DEPLETION DURING CHRONIC METABOLIC-ACIDOSIS IN THE RAT
Scandling, J. D., & Ornt, D. B. (1987). MECHANISM OF POTASSIUM-DEPLETION DURING CHRONIC METABOLIC-ACIDOSIS IN THE RAT. AMERICAN JOURNAL OF PHYSIOLOGY, 252(1), F122-F130.